SCHEMBL5582801

SCHEMBL5582801

CCN(CC)C(C)c1cc(NC(=O)c2ccc(-c3ccccc3)cc2)ccc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 11/20 0.55
▸ GALK1 P51570 1/20 0.48
▸ CASP6 P55212 1/20 0.48
▸ MCL1 Q07820 1/20 0.48
▸ PLEC Q15149 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ KMT2A Q03164 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ HTR2C P28335 1/20 0.47
▸ DEGS1 O15121 1/20 0.46
▸ PTPN1 P18031 1/20 0.46
▸ TRPV1 Q8NER1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20335182 0.77 ALDH1A1 (0.37) TDP1KMT2AKDM4EMEN1MAPT
SCHEMBL5582805 0.76 MCHR1 (0.64) MCHR1GALK1CASP6MCL1PLEC
SCHEMBL3296397 0.74 KMT2A (0.83) GALK1CASP6MCL1PLECTDP1
SCHEMBL6925688 0.73 MCHR1 (0.63) MCHR1SMN1; SMN2HTR2CTRPV1
SCHEMBL3296193 0.72 MCHR1 (0.69) MCHR1GALK1CASP6MCL1PLEC
SCHEMBL2398892 0.72 PGR (0.49) TDP1KMT2AKDM4EMEN1MAPT
SCHEMBL10758235 0.72 SIRT6 (0.64) GALK1CASP6MCL1PLECTDP1
SCHEMBL19285837 0.71 NR1I3 (0.34) KMT2AKDM4ELMNAMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL11581399 0.71 PGR (0.47) TDP1KMT2AKDM4EMEN1MAPT
SCHEMBL18030845 0.70 NR1H4 (0.67) MCHR1KMT2AKDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173498-A1 Melanin concentrating hormone antagonist MC1R, MCHR1, MCHR2 MCHR1 2/4885GALK1 4443/4885CASP6 4819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback